ELOXATIN (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the ELOXATIN drug offered from sanofi-aventis U.S. LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | oxaliplatin |
| SUBSTANCE NAME: | OXALIPLATIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-06-02 |
| END MARKETING DATE: | 0000-00-00 |
ELOXATIN HUMAN PRESCRIPTION DRUG Details:
| Item Description | ELOXATIN from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2006-06-02 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-0590_1dcf6847-980e-4e6f-a5ae-926a1706e248 |
| PRODUCT NDC: | 0024-0590 |
| APPLICATION NUMBER: | NDA021759 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers:
